What is the recommended approach for writing an insulin order for a patient with diabetes, considering their individual needs and medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Write an Insulin Order for a Patient

Start with 10 units of basal insulin (such as insulin glargine/Lantus) once daily at the same time each day for insulin-naive patients with type 2 diabetes, or use weight-based dosing of 0.1-0.2 units/kg/day, administered subcutaneously in the abdomen, thigh, or deltoid. 1, 2

Essential Components of Every Insulin Order

1. Specify the Exact Insulin Type and Formulation

  • Never write just "insulin" - always specify the exact product name (e.g., "insulin glargine" or "Lantus") to prevent medication errors 2
  • State the concentration (typically 100 units/mL for standard formulations) 2
  • Verify visually that the solution is clear and colorless with no particles before administration 2

2. Route and Administration Site

  • Write "subcutaneous" explicitly - never abbreviate as "SC" or "SQ" to avoid confusion 3, 2
  • Specify injection sites: abdomen (fastest absorption), upper arms, anterior/lateral thighs, or buttocks 3
  • Avoid a 2-inch radius around the navel 3
  • Order systematic rotation within one anatomical area (e.g., rotating within the abdomen) rather than switching between different body regions with each injection 3
  • Never order intravenous administration or insulin pump delivery for insulin glargine 2

3. Dosing Specifications

For Type 2 Diabetes (Insulin-Naive Patients):

  • Standard starting dose: 10 units once daily OR 0.1-0.2 units/kg body weight 1, 2
  • For severe hyperglycemia (blood glucose ≥300-350 mg/dL or A1C ≥10-12% with symptoms), start with 0.3-0.5 units/kg/day as total daily dose, split between basal and prandial insulin 1, 4

For Type 1 Diabetes:

  • Total daily dose: 0.5 units/kg/day (typical for metabolically stable patients) 1
  • Split as 50% basal insulin and 50% prandial insulin divided among three meals 1
  • Must order both basal and rapid-acting insulin - basal insulin alone is insufficient 2, 5

For Hospitalized Patients:

  • Insulin-naive or low-dose patients: 0.3-0.5 units/kg/day total daily dose, with half as basal insulin 1
  • High-risk patients (elderly >65 years, renal failure, poor oral intake): 0.1-0.25 units/kg/day 1
  • Patients on high-dose home insulin (≥0.6 units/kg/day): reduce by 20% upon admission 1

4. Timing Instructions

  • Specify "once daily at the same time each day" for basal insulin 1, 2
  • For rapid-acting insulin: order administration 0-15 minutes before meals 3, 5
  • Never write "as needed" for basal insulin - it must be scheduled 6, 7

5. Titration Protocol

Include explicit titration instructions in the order:

  • Increase by 2 units every 3 days if fasting glucose is 140-179 mg/dL 1
  • Increase by 4 units every 3 days if fasting glucose is ≥180 mg/dL 1
  • Target fasting plasma glucose: 80-130 mg/dL 1
  • If hypoglycemia occurs, reduce dose by 10-20% immediately 1

6. Monitoring Requirements

  • Order daily fasting blood glucose monitoring during titration 1
  • For hospitalized patients: point-of-care glucose testing before meals and bedtime (or every 4-6 hours if NPO) 4, 6
  • Order A1C measurement on admission if not available from prior 3 months 4, 6

7. Hypoglycemia Protocol

  • Order treatment for blood glucose ≤70 mg/dL with 15 grams of fast-acting carbohydrate 1
  • Specify that all insulin-requiring patients must carry 15g carbohydrate at all times 3
  • Include orders for glucagon availability for type 1 diabetes patients 3

Critical Thresholds and When to Advance Therapy

When basal insulin exceeds 0.5 units/kg/day, stop escalating and add prandial insulin instead - continuing to increase basal insulin beyond this threshold causes "overbasalization" with increased hypoglycemia risk and suboptimal control 1

Signs of Overbasalization to Monitor:

  • Basal insulin dose >0.5 units/kg/day 1
  • Bedtime-to-morning glucose differential ≥50 mg/dL 1
  • Hypoglycemia episodes 1
  • High glucose variability 1

Adding Prandial Insulin:

  • Start with 4 units of rapid-acting insulin before the largest meal OR 10% of current basal dose 1
  • Increase by 1-2 units or 10-15% every 3 days based on postprandial glucose 1

Sample Insulin Order Format

"Insulin glargine (Lantus) 10 units subcutaneously once daily at 8 PM. Inject into abdomen, rotating sites systematically within abdominal area. Check fasting blood glucose daily. Increase dose by 2 units every 3 days if fasting glucose 140-179 mg/dL, or by 4 units every 3 days if fasting glucose ≥180 mg/dL. Target fasting glucose 80-130 mg/dL. If blood glucose <70 mg/dL, give 15g fast-acting carbohydrate and reduce insulin dose by 10-20%. Continue metformin 1000mg twice daily unless contraindicated." 1, 2

Common Pitfalls to Avoid

  • Never order "sliding scale insulin" as monotherapy - this approach is strongly discouraged and associated with poor outcomes 6, 7
  • Never mix or dilute insulin glargine with other insulins due to its low pH 1, 2
  • Never delay insulin initiation in patients not achieving glycemic goals with oral medications 1
  • Never abruptly discontinue metformin when starting insulin - continue unless contraindicated 1
  • Never inject into areas of lipohypertrophy - this distorts absorption 2, 5
  • Never order intramuscular injection for routine insulin administration 3

Special Populations

Perioperative Orders:

  • Withhold metformin on day of surgery 4
  • Give half of NPH dose or 60-80% of long-acting analog the morning of surgery 4
  • Monitor glucose every 4-6 hours while NPO 4
  • Target glucose range: 80-180 mg/dL perioperatively 4

Patients on Corticosteroids:

  • Increase prandial and correction insulin by 40-60% in addition to basal insulin 1
  • For once-daily steroids, use NPH insulin for prandial coverage 4
  • For dexamethasone or continuous steroids, increase long-acting insulin to control fasting glucose 4

Enteral/Parenteral Nutrition:

  • Basal insulin needs are 30-50% of total daily insulin requirement 1
  • Start with 5 units NPH every 12 hours OR 10 units insulin glargine every 24 hours 1

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

insulin administration.

Diabetes Care, 2003

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Related Questions

How should I manage a patient with a blood glucose of 568 mg/dL after a 12‑unit insulin dose given in the office?
How many times should an insulin pre-filled syringe be primed for a patient with diabetes requiring insulin therapy?
Can Total Daily Dose (TDD) of insulin be calculated daily based on basal, bolus, and correction doses to adjust new basal and bolus dosing for hospitalized patients with impaired glucose control?
What alternatives are available for a patient with hyperglycemia (blood sugar 270) who is not responding to Empagliflozin (Empagliflozin)-metformin (metFORMIN) HCl 12.5-1000 MG and refuses insulin therapy?
What is the proper protocol for initiating and tapering insulin therapy in patients with diabetes?
Can a patient with latent tuberculosis infection (LTBI) start treatment for LTBI when initiating Humira (adalimumab) therapy?
Is muscle clenching a side effect of sertraline (Zoloft)?
Are steroids harmful to patients with pre-existing kidney disease or impaired renal function?
What antibiotic is used to treat an abscess underneath the eyelids?
What are the potential interactions between Ashwagandha and depression medications, such as Selective Serotonin Reuptake Inhibitors (SSRIs) like fluoxetine (Prozac) or sertraline (Zoloft), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) like venlafaxine (Effexor), or Tricyclic Antidepressants (TCAs) like amitriptyline (Elavil)?
Are codes J0834 (Injection, Cosyntropin, 0.25 mg) and 80400 (Stimulation Panel) medically necessary for a 33-year-old female patient with hypotension, weight fluctuations, and symptoms suggestive of adrenal insufficiency, including daily headaches, cold intolerance, and difficulty maintaining weight, who has a history of menstrual irregularities, pituitary microadenoma, and Hashimoto's antibodies, with normal morning cortisol and adrenocorticotropic hormone (ACTH) levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.